The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

Share Price Information for Mandarin In.sg (MDO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.06
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.06
MDO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 May 2022 10:27

RNS Number : 1108M
Mandarin Oriental International Ltd
19 May 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

19th May 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2022.

 

Trading conditions in the period improved in most parts of the world compared to the first quarter of 2021. Government restrictions on international and domestic travel, however, hampered the operating performance in Asia, with properties in China being particularly affected, and these challenges have continued into the second quarter.

 

In Europe, Middle East and Africa ('EMEA') and America, occupancy levels were lower than pre-pandemic levels for most properties, but room rates have held up well and are generally higher than in 2019. In Asia, both occupancy and room rates have remained substantially below pre-pandemic levels.

 

During the first quarter, the Group announced three new properties, in the Maldives, Costa Navarino and Cairo, increasing the Group's pipeline of new hotels and residences under development to 25.

 

The Group recorded an EBITDA loss of US$1 million in the first quarter. The impact of continued travel restrictions in much of Asia was offset by a more robust performance in EMEA and America and tightly-controlled corporate costs. Owned hotels and the management business recorded an underlying EBITDA loss of US$6 million and an underlying EBITDA profit of US$5 million, respectively.

 

Underlying losses (unaudited) for the Group were much improved compared to 2021, with the management business recording a marginal underlying profit (unaudited) in the period. As noted in the Group's 2021 full year results in March 2022, the outlook continues to improve in most markets, but there remains uncertainty in relation to China.

 

The Group's financial position is robust. Net debt at 31st March 2022 was US$542 million, and the Group held US$159 million of cash reserves and US$317 million in available, committed debt facilities. Gearing was 11% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley 

(852) 2895 9288

Matthew Bishop 

(852) 2895 9288

Brunswick Group Limited

Sunitha Chalam

(65) 6426 8188

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKKLBFLELLBBZ
Date   Source Headline
23rd Dec 201510:27 amRNSDirector/PDMR Shareholding
30th Nov 20159:35 amRNSDirector Declaration
26th Nov 20159:18 amRNSDirectorate Change
26th Nov 20159:15 amRNSJames Riley to Succeed Edouard Ettedgui as GroupCE
26th Nov 20159:10 amRNSDirectorate Change
4th Nov 20159:16 amRNSInterim Management Statement
2nd Oct 201510:47 amRNSDirector/PDMR Shareholding
30th Sep 201511:04 amRNSDirector/PDMR Shareholding
30th Sep 201510:14 amRNSDividend
30th Sep 201510:12 amRNSTotal Voting Rights
25th Sep 201511:09 amRNSDirector/PDMR Shareholding
25th Sep 201510:15 amRNSBlocklisting Interim Review
23rd Sep 201510:54 amRNSDirector/PDMR Shareholding
3rd Aug 201511:20 amRNSDirector Declaration
30th Jul 201510:16 amRNSDirectorate Change
30th Jul 201510:07 amRNSHalf Yearly Results - 6 months ended 30 June 2015
2nd Jul 201510:19 amRNSNotice of 2015 Half-Yearly Results
30th Jun 201510:15 amRNSTotal Voting Rights
9th Jun 201511:40 amRNSDirector/PDMR Shareholding
29th May 201510:51 amRNSTotal Voting Rights
22nd May 20157:00 amRNSMandarin Oriental JV to Acquire Hotel Ritz, Madrid
14th May 20158:39 amRNSAdditional Listing
6th May 20152:09 pmRNSNon-Routine Resolutions submitted via NSM
6th May 20151:59 pmRNSResult of AGM
30th Apr 201511:33 amRNSTotal Voting Rights
29th Apr 201510:46 amRNSDividend
9th Apr 20151:24 pmRNSDirector/PDMR Shareholding
9th Apr 201510:30 amRNSAnnual Financial Report
8th Apr 201510:16 amRNSTotal Voting Rights
7th Apr 20155:01 pmRNSResults of 1 for 4 Rights Issue
7th Apr 201510:13 amRNSDirector/PDMR Shareholding
30th Mar 201510:32 amRNSDirector Declaration
25th Mar 20159:18 amRNSDirector/PDMR Shareholding
25th Mar 20159:16 amRNSBlocklisting Interim Review
20th Mar 20159:15 amRNSDirector/PDMR Shareholding
16th Mar 20158:29 amRNSAdmission to Trading
12th Mar 20159:42 amRNSPublication of Prospectus
5th Mar 201510:39 amRNSDirector Declaration
5th Mar 20159:20 amRNS1 FOR 4 RIGHTS ISSUE TO RAISE US$316 MILLION
5th Mar 20159:16 amRNS2014 Preliminary Announcement of Results
2nd Feb 20159:24 amRNSNotice of 2014 Final Results
31st Dec 20147:28 amRNSTotal Voting Rights
2nd Dec 201410:14 amRNSDirector/PDMR Shareholding
5th Nov 201410:08 amRNSInterim Management Statement
30th Sep 201410:10 amRNSDividend
30th Sep 201410:10 amRNSTotal Voting Rights
25th Sep 201410:07 amRNSBlocklisting Interim Review
31st Jul 201410:08 amRNSTotal Voting Rights
31st Jul 201410:06 amRNSHalf Yearly Report
3rd Jul 201411:15 amRNSNotice of 2014 Half-Yearly Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.